Drugs / Jia Shen Tablet
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06669169 | Jan 2025 → Dec 2026 expected | heart failure | Tasly Pharmaceutical Group Co., Ltd | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jia Shen Tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06669169 ↗ |
| Route | Oral | “take orally” NCT06669169 ↗ |